tiprankstipranks
Angion Biomedica (ANGN)
NASDAQ:ANGN

Angion Biomedica (ANGN) Financial Statements

0 Followers

Angion Biomedica Financial Overview

Angion Biomedica's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Angion Biomedica is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 0.00$ 653.00K$ 1.65M
Gross Profit-----
EBIT$ -4.68M$ -6.84M$ -6.25M$ -9.04M$ -14.48M
EBITDA$ -4.64M$ -6.58M$ -5.96M$ -8.80M$ -14.26M
Net Income Common Stockholders$ -4.54M$ -6.44M$ -8.99M$ -9.14M$ -14.24M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 29.20M$ 50.50M$ 55.14M$ 63.37M$ 73.00M
Total Assets$ 41.75M$ 52.79M$ 61.32M$ 70.81M$ 81.26M
Total Debt$ 297.00K$ 3.71M$ 3.96M$ 4.20M$ 4.43M
Net Debt$ -28.90M$ -46.79M$ -51.19M$ -59.17M$ -68.57M
Total Liabilities$ 2.10M$ 9.02M$ 11.11M$ 11.05M$ 14.06M
Stockholders Equity$ 39.65M$ 43.77M$ 50.21M$ 59.76M$ 67.20M
Cash Flow-
Free Cash Flow$ -8.03M$ -4.43M$ -8.41M$ -9.90M$ -15.65M
Operating Cash Flow$ -8.03M$ -4.43M$ -8.41M$ -9.90M$ -15.65M
Investing Cash Flow$ -10.00M-$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ -3.27M$ -15.00K$ -17.00K$ -14.00K$ -14.00K
Currency in USD

Angion Biomedica Earnings and Revenue History

Angion Biomedica Debt to Assets

Angion Biomedica Cash Flow

Angion Biomedica Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis